TRACEY GRUPP: Open Payments
NPI 1831803642 · PRINCESS ANNE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 13 payments from 9 companies in 2025. Trend: 2023 $127 · 2024 $431 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $125 |
| Gilead Sciences, Inc. | 1 | $98 |
| Lilly USA, LLC | 3 | $67 |
| Novo Nordisk Inc | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Repatha, Epclusa, MOUNJARO, Wegovy, Kerendia, TZIELD, APTIMA, FARXIGA.
Industry payments across MD — which companies pay providers there.
